全球组织诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

组织诊断市场预计将从 2025 年的 72.4 亿美元成长到 2034 年的 157.8 亿美元，2026 年至 2034 年的复合年增长率为 9.04%。

受癌症患者数量不断增加以及对精准快速诊断解决方案需求日益增长的推动，组织诊断市场预计将迎来显着增长。随着医疗机构致力于透过早期检测和个人化治疗方案改善患者预后，对先进组织诊断技术的需求呈现爆炸性成长。组织病理学、免疫组织化学和分子诊断领域的创新正在提高组织分析的准确性和效率，使医疗专业人员能够就患者照护做出明智的决策。数位病理学和人工智慧的整合正在进一步变革该领域，实现更精确的影像分析和更优化的检查室工作流程。

此外，对个人化医疗日益增长的关注正在影响组织诊断市场。对癌症生物学认识的不断深入，增加了对能够识别与不同癌症类型相关的特定生物标记的诊断测试的需求。这一趋势正在推动伴随诊断的发展，以指导治疗决策并改善治疗效果。此外，对肿瘤学研发的日益重视也推动了组织诊断领域的创新，促使新型检测方法和技术的出现，从而提升了诊断能力。

此外，旨在提高癌症筛检和诊断水准的宣传活动和措施的不断增加，也促进了组织诊断市场的成长。随着患者对早期检测重要性的认识不断提高，对可靠且便捷的诊断解决方案的需求预计将会上升。学术机构、研究组织和产业相关人员之间的合作也在推动组织诊断技术的进步，确保新技术能够满足医疗服务提供者和患者不断变化的需求。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球组织诊断市场（依产品划分）

• 市场分析、洞察与预测
• 耗材（抗体、试剂盒、试剂、探针）
• 设备 A（载玻片染色系统、扫描器、组织处理系统、其他设备（自动盖玻片机、切片机、包埋系统、石蜡分配器和载玻片标籤机））

5. 全球组织诊断市场（依技术划分）

• 市场分析、洞察与预测
• 免疫组织化学
• 原位杂合反应
• 数位病理学和工作流程管理
• 特殊染色

6. 全球组织诊断市场（依疾病类型划分）

• 市场分析、洞察与预测
• 乳癌
• 胃癌
• 淋巴瘤
• 摄护腺癌
• 非小细胞肺癌
• 其他疾病类型（神经系统疾病、心血管疾病、免疫系统疾病、感染疾病、骨癌、结肠癌、甲状腺癌、子宫颈癌、皮肤癌、胆囊癌、B型肝炎病毒、EBEB病毒、肝炎、肌肉萎缩症、肾细胞癌、多形性肉瘤）

7. 全球组织诊断市场（以最终用户划分）

• 市场分析、洞察与预测
• 医院
• 研究实验室
• 製药公司
• 受託研究机构（CRO）
• 其他最终用户（参考实验室和学术实验室）

8. 全球组织诊断市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • PHC Holdings Corporation
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • GE Healthcare
  • Cell Signaling TechnologyInc
  • BioGenex
  • Siemens

The Tissue Diagnostics Market size is expected to reach USD 15.78 Billion in 2034 from USD 7.24 Billion (2025) growing at a CAGR of 9.04% during 2026-2034.

The tissue diagnostics market is poised for significant growth, driven by the increasing prevalence of cancer and the rising demand for accurate and timely diagnostic solutions. As healthcare providers seek to improve patient outcomes through early detection and personalized treatment plans, the need for advanced tissue diagnostic technologies is surging. Innovations in histopathology, immunohistochemistry, and molecular diagnostics are enhancing the accuracy and efficiency of tissue analysis, enabling healthcare professionals to make informed decisions regarding patient care. The integration of digital pathology and artificial intelligence is further transforming the landscape, allowing for more precise image analysis and improved workflow in laboratories.

Moreover, the growing emphasis on personalized medicine is influencing the tissue diagnostics market. As the understanding of cancer biology advances, there is a rising demand for diagnostic tests that can identify specific biomarkers associated with different cancer types. This trend is driving the development of companion diagnostics that guide treatment decisions and improve therapeutic outcomes. Additionally, the increasing focus on research and development in oncology is fostering innovation in tissue diagnostics, leading to the introduction of novel assays and technologies that enhance diagnostic capabilities.

Furthermore, the rise of awareness campaigns and initiatives aimed at improving cancer screening and diagnosis is contributing to the growth of the tissue diagnostics market. As patients become more informed about the importance of early detection, the demand for reliable and accessible diagnostic solutions is expected to rise. Collaborations between academic institutions, research organizations, and industry players are also driving advancements in tissue diagnostics, ensuring that new technologies meet the evolving needs of healthcare providers and patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables (Antibodies, Kits, Reagents, Probes)
• InstrumentsA (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers))

By Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology & Workflow Management
• Special Staining

By Disease Type

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Cancer
• Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.)

By End User

• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users (Reference Laboratories And Academic Research Laboratories)

COMPANIES PROFILED

• F HoffmannLa Roche Ltd, Danaher Corporation, PHC Holdings Corporation, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Abbott Laboratories, GE Healthcare, Cell Signaling Technology, Inc, BioGenex, Siemens

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TISSUE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables (Antibodies, Kits, Reagents, Probes) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. InstrumentsA (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TISSUE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunohistochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. In Situ Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Digital Pathology & Workflow Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Special Staining Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TISSUE DIAGNOSTICS MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Disease Type
• 6.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Gastric Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Non-small Cell Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TISSUE DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other End Users (Reference Laboratories And Academic Research Laboratories) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TISSUE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Disease Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Disease Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Disease Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Disease Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Disease Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TISSUE DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 F. Hoffmann-La Roche Ltd
  • 10.2.2 Danaher Corporation
  • 10.2.3 PHC Holdings Corporation
  • 10.2.4 Agilent Technologies Inc
  • 10.2.5 Thermo Fisher Scientific Inc
  • 10.2.6 Abbott Laboratories
  • 10.2.7 GE Healthcare
  • 10.2.8 Cell Signaling TechnologyInc
  • 10.2.9 BioGenex
  • 10.2.10 Siemens